54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
00:32 UTC
|
ORCL
Oracle
|
◎ Target | Karl Keirstead ★★★☆☆ #1063 | Buy | $285.00→ $245.00-14.0% |
|
Aug 07
00:32 UTC
|
OPRT
Oportun Financial
|
◎ Target | Kyle Joseph ★★☆☆☆ #2619 | Overweight | $7.00→ $8.00+14.3% |
|
Aug 07
00:32 UTC
|
OPLN
Openlane
|
◎ Target | John Babcock ★★★☆☆ #2025 | Overweight | $46.00→ $49.00+6.5% |
|
Aug 07
00:32 UTC
|
ONC
BeOne Medicines
|
◎ Target | Yaron Werber ★★★☆☆ #2253 | Buy | $424.00→ $454.00+7.1% |
|
Aug 07
00:32 UTC
|
ONC
BeOne Medicines
|
◎ Target | Peter Lawson ★★★☆☆ #2098 | Overweight | $403.00→ $407.00+1.0% |
|
Aug 07
00:32 UTC
|
ONC
BeOne Medicines
|
◎ Target | Reni J. Benjamin not yet tracked | Market Outperform | $396.00→ $405.00+2.3% |
|
Aug 07
00:32 UTC
|
ONC
BeOne Medicines
|
◎ Target | Michael Schmitz not yet tracked | Buy | $420.00→ $430.00+2.4% |
|
Aug 07
00:32 UTC
|
ONC
BeOne Medicines
|
◎ Target | Leonid Timashev ★★★☆☆ #1391 | Outperform | $451.00→ $450.00-0.2% |
|
Aug 07
00:32 UTC
|
ONC
BeOne Medicines
|
◎ Target | Gregory Renza ★★★☆☆ #1227 | Buy | $416.00→ $418.00+0.5% |
|
Aug 07
00:32 UTC
|
OC
Owens Corning
|
◎ Target | Keith Hughes ★★★☆☆ #1642 | Hold | $125.00→ $140.00+12.0% |
|
Aug 07
00:32 UTC
|
OC
Owens Corning
|
◎ Target | Matthew Bouley ★★★☆☆ #1427 | Overweight | $170.00→ $177.00+4.1% |
|
Aug 07
00:32 UTC
|
NYT
New York Times
|
◎ Target | Kannan Venkateshwar ★★★☆☆ #2061 | Equal Weight | $66.00→ $63.00-4.5% |
|
Aug 07
00:32 UTC
|
NXT
NEXT
|
◎ Target | firm only | Neutral | £132→ £155+17.4% |
|
Aug 07
00:32 UTC
|
NXT
NEXT
|
◎ Target | firm only | Buy | £180→ £187+3.9% |
|
Aug 07
00:32 UTC
|
NXT
NEXT
|
◎ Target | firm only | Neutral | £130.30→ £140.40+7.8% |
|
Aug 07
00:32 UTC
|
NNN
NNN REIT
|
◎ Target | Brad Heffern ★★★★☆ #362 | Sec→ r Perform | $44.00→ $47.00+6.8% |
|
Aug 07
00:32 UTC
|
NICE
NiCE
|
◎ Target | Clark Wright ★★★★★ #141 | Buy | $110.00→ $115.00+4.5% |
|
Aug 07
00:32 UTC
|
NAMS
NewAmsterdam Pharma
|
◎ Target | Leonid Timashev ★★★☆☆ #1391 | Outperform | $51.00→ $50.00-2.0% |
|
Aug 07
00:32 UTC
|
MVBF
Mvb Financial
|
◎ Target | Catherine Mealor ★★★★☆ #364 | Outperform | $32.00→ $34.00+6.2% |
|
Aug 07
00:32 UTC
|
MTSI
MACOM Technology Solutions
|
◎ Target | N. Quinn Bolton not yet tracked | Buy | $400.00→ $410.00+2.5% |
|
Aug 07
00:32 UTC
|
MSI
Motorola Solutions
|
◎ Target | Andrew Spinola ★★★☆☆ #1636 | Buy | $510.00→ $520.00+2.0% |
|
Aug 07
00:32 UTC
|
MSI
Motorola Solutions
|
◎ Target | Joseph Cardoso ★★☆☆☆ #2590 | Overweight | $525.00→ $545.00+3.8% |
|
Aug 07
00:32 UTC
|
MSI
Motorola Solutions
|
◎ Target | Tim Long ★★★☆☆ #1976 | Overweight | $509.00→ $529.00+3.9% |
|
Aug 07
00:32 UTC
|
MSI
Motorola Solutions
|
◎ Target | James Fish ★★★☆☆ #1704 | Overweight | $503.00→ $530.00+5.4% |
|
Aug 07
00:32 UTC
|
MRAM
Everspin Tech
|
◎ Target | Neil Young not yet tracked | Buy | $18.50→ $19.00+2.7% |
|
Aug 07
00:32 UTC
|
MPLX
Mplx
|
◎ Target | Theresa Chen ★★★☆☆ #1737 | Overweight | $59.00→ $63.00+6.8% |
|
Aug 07
00:32 UTC
|
MPC
Marathon Petroleum
|
◎ Target | John Royall not yet tracked | Overweight | $343.00→ $344.00+0.3% |
|
Aug 07
00:32 UTC
|
MPC
Marathon Petroleum
|
◎ Target | Theresa Chen ★★★☆☆ #1737 | Overweight | $289.00→ $321.00+11.1% |
|
Aug 07
00:32 UTC
|
MNKD
MannKind
|
◎ Target | Benjamin Burnett ★★★☆☆ #1802 | Overweight | $14.00→ $13.00-7.1% |
|
Aug 07
00:32 UTC
|
MKSI
MKS
|
◎ Target | James Ricchiuti ★★☆☆☆ #2610 | Buy | $360.00→ $390.00+8.3% |
|
Aug 07
00:32 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Joseph Thome ★★☆☆☆ #2865 | Buy | $145.00→ $140.00-3.4% |
|
Aug 07
00:32 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Lisa Walter ★★☆☆☆ #2744 | Outperform | $148.00→ $135.00-8.8% |
|
Aug 07
00:32 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Jonathan Wolleben ★★☆☆☆ #2674 | Market Outperform | $146.00→ $137.00-6.2% |
|
Aug 07
00:32 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2778 | Buy | $185.00→ $140.00-24.3% |
|
Aug 07
00:32 UTC
|
MIAX
Miami International
|
◎ Target | Chris Brendler ★★☆☆☆ #2880 | Buy | $61.00→ $62.00+1.6% |
|
Aug 07
00:32 UTC
|
MGNI
Magnite
|
◎ Target | Daniel L. Kurnos not yet tracked | Buy | $30.00→ $33.00+10.0% |
|
Aug 07
00:32 UTC
|
MGNI
Magnite
|
◎ Target | Matthew Swanson ★★★☆☆ #1014 | Outperform | $20.00→ $27.00+35.0% |
|
Aug 07
00:32 UTC
|
MGNI
Magnite
|
◎ Target | Tyler DiMatteo ★★★☆☆ #1016 | Buy | $20.00→ $27.00+35.0% |
|
Aug 07
00:32 UTC
|
MGNI
Magnite
|
◎ Target | Shyam Patil ★★★☆☆ #1258 | Positive | $22.00→ $30.00+36.4% |
|
Aug 07
00:32 UTC
|
MGNI
Magnite
|
◎ Target | Daniel Day not yet tracked | Buy | $20.00→ $27.00+35.0% |
|
Aug 07
00:32 UTC
|
MGNI
Magnite
|
◎ Target | Barton Crockett ★★★★☆ #650 | Buy | $39.00→ $40.00+2.6% |
|
Aug 07
00:32 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Equal Weight | C$56.00→ C$59.00+5.4% |
|
Aug 07
00:32 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Buy | C$65.00→ C$67.00+3.1% |
|
Aug 07
00:32 UTC
|
METC
Ramaco Resources
|
◎ Target | Nathan P. Martin not yet tracked | Buy | $38.00→ $26.00-31.6% |
|
Aug 07
00:32 UTC
|
METC
Ramaco Resources
|
◎ Target | Brian Lee not yet tracked | Neutral | $13.00→ $11.00-15.4% |
|
Aug 07
00:32 UTC
|
MET
MetLife
|
◎ Target | Alex Scott ★★★★☆ #468 | Overweight | $94.00→ $97.00+3.2% |
|
Aug 07
00:32 UTC
|
MELI
MercadoLibre
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Overweight | $2,150.00→ $2,300.00+7.0% |
|
Aug 07
00:32 UTC
|
MDLN
Medline
|
◎ Target | Rick Wise ★★★★★ #31 | Buy | $50.00→ $45.00-10.0% |
|
Aug 07
00:32 UTC
|
MDLN
Medline
|
◎ Target | Jailendra Singh ★★★★★ #174 | Buy | $56.00→ $47.00-16.1% |
|
Aug 07
00:32 UTC
|
MDLN
Medline
|
◎ Target | Ryan Halsted ★★★★★ #302 | Outperform | $53.00→ $46.00-13.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.